ABLATION OF THE MURINE ALPHA-MYOSIN HEAVY-CHAIN GENE LEADS TO DOSAGE EFFECTS AND FUNCTIONAL DEFICITS IN THE HEART

Citation
Wk. Jones et al., ABLATION OF THE MURINE ALPHA-MYOSIN HEAVY-CHAIN GENE LEADS TO DOSAGE EFFECTS AND FUNCTIONAL DEFICITS IN THE HEART, The Journal of clinical investigation, 98(8), 1996, pp. 1906-1917
Citations number
29
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
00219738
Volume
98
Issue
8
Year of publication
1996
Pages
1906 - 1917
Database
ISI
SICI code
0021-9738(1996)98:8<1906:AOTMAH>2.0.ZU;2-B
Abstract
The alpha-myosin heavy chain (alpha-MyHC) is the major contractile pro tein expressed in the myocardium of adult mice. We have produced mice carrying a null mutation of alpha-MyHC by homologous recombination in murine ES cells, Homozygous null animals die between 11 and 12 d in ut ero of gross heart defects, while alpha-MyHC(+/-) heterozygotes surviv e and appear externally normal. The presence of a single functional al pha-MyHC(+) allele in heterozygous animals results in reduced levels o f the transcript and protein as well as fibrosis and alterations in sa rcomeric structure. Examination of heart function using a working hear t preparation revealed severe impairment of both contractility and rel axation in a subset of the alpha-MyHC(+/-) animals. Thus, two alpha-My HC(+) alleles are necessary for normal cardiac development, and hemizy gosity for the normal allele can result in altered cardiac function.